Alpa Laboratories Ltd share price logo

Alpa Laboratories Ltd (ALPA)

₹91.490.77%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹89.46
    ₹92.47
  • 52 Week's Low

    52 Week's High

    ₹68.3
    ₹115
1 Month Return+ 2.76 %
3 Month Return-6.01 %
1 Year Return+ 31.87 %
Previous Close₹90.79
Open₹91.84
Volume46.14K
Upper Circuit-
Lower Circuit-
Market Cap₹191.02Cr

Key Statistics

P/E Ratio11.25
PEG Ratio5.28
Market Cap₹191.02 Cr
P/B Ratio0.78
EPS0.48

Company Information

M/s Alpa Laboratories, established in 1967, was incorporated as a private limited company in 1988 and was converted to a public limited company in 1998. Their products include ethical drugs, generic drugs, OTC, and veterinary products in various dosage forms under the trade mark Alpa, which is a registered trademark owned by a promoter group company. They have also manufactured formulations for national and international companies such as Cipla and Zydus Cadila, and supplied contract manufacturing services in countries such as Liberia and Nigeria. The established product-marketing network covers both metro and mini metro cities, and business is categorized into Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The company commenced commercial production at their new Rau (Indore District, Madhya Pradesh) unit in 1999.

Share Price: ₹91.49 per share as on 25 Jul, 2024 04:01 PM
Market Capitalisation: ₹191.02Cr as of today
Revenue: ₹23.61Cr as on March 2024 (Q1 24)
Net Profit: ₹3.55Cr as on March 2024 (Q1 24)
Listing date: 06 Aug, 2007
Chairperson Name: Mahendra Singh Chawla
OrganisationAlpa Laboratories Ltd
HeadquartersIndore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Alpa Laboratories Ltd

  • Alpa Laboratories Ltd's P/E Ratio Lower Than Market - 03 Jun, 2024

    Alpa Laboratories Limited has a lower P/E ratio than the market despite rapid earnings growth. Shareholders accepting significantly lower selling prices suggest unobserved threats to earnings and potential future volatility.

Insights on Alpa Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 42.20% to 42.35% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 89.7% return, outperforming this stock by 57.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.2% return, outperforming this stock by 47.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 57.29% of holdings in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 5.79 Cr → 3.55 Cr (in ₹), with an average decrease of 21.7% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.50% to 0.36% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ALPA stock has moved down by -6.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 35.35 Cr → 27.59 Cr (in ₹), with an average decrease of 11.7% per quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹23.61Cr
↓13.55%
Net Income
₹3.55Cr
↓21.29%
Net Profit Margin
15.04%
↓8.90%
2023Y/Y Change
Revenue
₹92.96Cr
↓17.20%
Net Income
₹12.58Cr
↓10.72%
Net Profit Margin
13.53%
↑7.81%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹177.49Cr
↑7.48%
Total Liabilities
₹32.96Cr
↓1.61%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹8.82Cr
↑300.91%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
57.29%
0.00
Foreign Institutions
0.36%
-28.74
Mutual Funds
0%
0.00
Retail Investors
42.35%
0.34
Others
0%
0.00

Key Indicators

Alpa Laboratories Ltd Valuation

Alpa Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (7.54x)

October 25, 2021

Today (11.25x)

July 24, 2024

Industry (56.38x)

July 24, 2024

Highest (65.88x)

July 22, 2019

LowHigh

Earnings and Dividends

  • Alpa Laboratories Ltd Earnings Results

    Alpa Laboratories Ltd’s net profit fell -23.66% since last year same period to ₹3.55Cr in the Q4 2023-2024. On a quarterly growth basis, Alpa Laboratories Ltd has generated -21.29% fall in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Alpa Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Alpa Laboratories Ltd shares.

Alpa Laboratories Ltd (ALPA) share price today is ₹91.49

Alpa Laboratories Ltd is listed on NSE

Alpa Laboratories Ltd is listed on BSE

  • Today’s highest price of Alpa Laboratories Ltd is ₹92.47.
  • Today’s lowest price of Alpa Laboratories Ltd is ₹89.46.

PE Ratio of Alpa Laboratories Ltd is 11.25

PE ratio = Alpa Laboratories Ltd Market price per share / Alpa Laboratories Ltd Earnings per share

Today’s traded volume of Alpa Laboratories Ltd(ALPA) is 46.14K.

Today’s market capitalisation of Alpa Laboratories Ltd(ALPA) is ₹191.02Cr.

Alpa Laboratories Ltd(ALPAPrice
52 Week High
₹115
52 Week Low
₹68.3

Alpa Laboratories Ltd(ALPA) share price is ₹91.49. It is down -20.44% from its 52 Week High price of ₹115

Alpa Laboratories Ltd(ALPA) share price is ₹91.49. It is up 33.95% from its 52 Week Low price of ₹68.3

Alpa Laboratories Ltd(ALPAReturns
1 Day Returns
0.7%
1 Month Returns
2.76%
3 Month Returns
-6.01%
1 Year Returns
31.87%